GSK Consumer Healthcare re-launches Crocin Pain Relief

New Delhi – 31st October 2019: GSK Consumer Healthcare strengthens its position in the pain relief category by re-launching the iconic Crocin Pain Relief, Crocin Pain Relief, which is especially designed to offer relief from headaches. Delivering targeted pain relief, its formula contains clinically proven ingredients, that act at the center of pain according to report published in health.economictimes.indiatimes.com

Naveed Ahmed, Area Marketing Director, Wellness, GSK Consumer Healthcare said, “In today’s times when everyone has multiple priorities, dealing with a headache should never come in the way of everyday life. Keeping this in mind, GSK Consumer Healthcare is excited to re-launch Crocin Pain Relief, a solution that is specially designed as an effective yet gentle product for everyday headaches.

As part of the launch, the brand has released three relatable video films that bring alive the condition and its impact on peoples’ lives. The launch is being supported with an awareness campaign across television and digital platforms. The awareness plan also includes an extensive outreach to Heath care Professionals and chemists to create awareness and education on the condition and the product benefits.

Crocin has been a trusted household healthcare name for decades and enjoys a strong equity with consumers. It is India’s largest selling analgesic brand with a range of variants in both solid and liquid format. More than 25 million tablets of Crocin are sold each day in India. That’s nearly 25 tablets every second around the clock. GSK markets five varients of Crocin namely Crocin Advance, Crocin 650 Mg, Crocin Pain Relief, Crocin Cold & Flu and Crocin’s Children Range (Crocin 120, Crocin 140, Croin Drops).